We are thrilled to announce the launch of our newly optimized IPF (Idiopathic Pulmonary Fibrosis) preclinical disease model. This model release is positioned to expand research opportunities in the fight against lung disease, providing researchers with an advanced tool to unlock new insights and accelerate the quest for effective treatments. Most remarkable about this optimization […]
We are extremely excited to announce the successful validation of the MC903 Atopic Dermatitis Model. This preclinical model, the 62nd in MLM’s growing lineup of validated models, provides an ideal solution for companies involved in translational and preclinical research in the field of atopic dermatitis. Atopic dermatitis, a prevalent chronic inflammatory skin condition, presents significant
Enhancing Preclinical Trials with Comprehensive Histology Lab Services by Marlena Jelec, MD, Histology Business Development Manager @ MLM Medical Labs In the realm of preclinical research, where potential therapeutic interventions are rigorously tested before reaching human trials, accuracy and reliability are paramount. Histology plays a pivotal role in evaluating the safety and efficacy of new
Enhancing Preclinical Trials with Comprehensive Histology Lab Services Read More »
Shake Up NASH Research with MLMJoin the Preclinical Dance Party! by Katie Dineen, Preclinical Business Development @ MLM Medical Labs Attention all scientists ready to hit the dance floor of NASH research! With International NASH Day upon us, let MLM Medical Labs be your dance partner of choice for all things NASH preclinical research. At
Let MLM’s Preclinical NASH Model Jumpstart Your Research Read More »
With the proliferation of metabolic-related diseases such as diabetes, biopharmaceutical companies are working to develop new therapies that address these conditions. Companies large and small are expending precious resources to find treatments for people who have developed diabetes to lessen the likelihood of serious complications such as diabetic retinopathy, coronary artery disease and stroke.
Considerations for Conducting Clinical Studies on Metabolic Conditions Read More »
